Clinical Trial Update: A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study results assess niraparib in combination with bevacizumab as maintenance therapy for advanced ovarian cancer after response to first-line platinum-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Niraparib (Niraparib)

Snippet

Sponsor: Tesaro, Inc. | Conditions: Ovarian Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2022-01-19